Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Statements of Cash Flows

v3.20.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating activities:    
Net loss for the year $ (41,907,079) $ (22,639,272)
Items not involving cash:    
Amortization 32,555 29,041
Stock based compensation 1,651,119 1,505,625
Other share compensation   66,234
Warrant liability-fair value adjustment (19,800,645) (17,095,220)
Warrant liability-foreign exchange adjustment 17,687 (984,462)
Non-cash issuance costs 744,501  
Changes in non-cash working capital items:    
Amounts receivable, prepaid expenses and deposits 8,336,486 (6,508,259)
Accounts payable and accrued liabilities 4,965,008 4,229,536
Cash used in operating activities (45,960,368) (41,396,777)
Financing activities:    
Net proceeds from issuance of common shares and warrants 35,766,754 27,158,114
Repayment of lease liabilities (5,100)  
Cash provided by financing activities 35,761,654 27,158,114
Investing Activities:    
Cost of Patents (458,037) (420,587)
Cash used in investing activities (458,037) (420,587)
Decrease in cash and cash equivalents (10,656,751) (14,659,250)
Cash and cash equivalents, beginning of the year 11,471,243 26,130,493
Cash and cash equivalents, end of the year 814,492 11,471,243
Cash and cash equivalents comprise:    
Cash 141,768 100,130
Cash equivalents 672,724 11,371,113
Cash and cash equivalents, end of the year $ 814,492 $ 11,471,243